Developed in the Belgian facilities of GSK's pharmaceutical laboratory, Arexvy is the world's first vaccine to combat Respiratory Syncytial Virus (RSV).
Classic blood pressure inhibitors may also help our immune system fight cancer cells better. This was discovered by scientists from UCLouvain's de Duve Institute, among others.
Researchers from the ULB Neuroscience Institute have shown that inactivation of a specific part of the brain, the activating circuit in the ventral region of the striatum, caused behaviours such as a